RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Geou-Yarh Liou to Carcinoma in Situ

This is a "connection" page, showing publications Geou-Yarh Liou has written about Carcinoma in Situ.
Connection Strength

1.754
  1. Liou GY, Bastea L, Fleming A, D?ppler H, Edenfield BH, Dawson DW, Zhang L, Bardeesy N, Storz P. The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. Cell Rep. 2017 05 16; 19(7):1322-1333.
    View in: PubMed
    Score: 0.593
  2. Liou GY, D?ppler H, Braun UB, Panayiotou R, Scotti Buzhardt M, Radisky DC, Crawford HC, Fields AP, Murray NR, Wang QJ, Leitges M, Storz P. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nat Commun. 2015 Feb 20; 6:6200.
    View in: PubMed
    Score: 0.508
  3. Liou GY, Leitges M, Storz P. Pancreatic oncogenic signaling cascades converge at Protein Kinase D1. Cell Cycle. 2015; 14(10):1489-90.
    View in: PubMed
    Score: 0.503
  4. Ding L, Liou GY, Schmitt DM, Storz P, Zhang JS, Billadeau DD. Glycogen synthase kinase-3? ablation limits pancreatitis-induced acinar-to-ductal metaplasia. J Pathol. 2017 09; 243(1):65-77.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support